JPH0776585A - Production of 6,7-dihydro-5h-pyrazolo(1,2-a)(1,2,4)triazoliums - Google Patents
Production of 6,7-dihydro-5h-pyrazolo(1,2-a)(1,2,4)triazoliumsInfo
- Publication number
- JPH0776585A JPH0776585A JP5245911A JP24591193A JPH0776585A JP H0776585 A JPH0776585 A JP H0776585A JP 5245911 A JP5245911 A JP 5245911A JP 24591193 A JP24591193 A JP 24591193A JP H0776585 A JPH0776585 A JP H0776585A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- compound
- group
- formula
- expressed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明はカルバペネム系抗生物質
の合成中間体として有用な6,7−ジヒドロ−5H−ピ
ラゾロ[1,2−a][1,2,4]トリアゾリウム類
の製造法に関する。FIELD OF THE INVENTION The present invention relates to a method for producing 6,7-dihydro-5H-pyrazolo [1,2-a] [1,2,4] triazoliums useful as synthetic intermediates for carbapenem antibiotics. .
【0002】[0002]
【従来の技術】近年、強力で広範囲な抗菌活性を有する
抗生物質としてカルバペネム系化合物が臨床に利用され
るようになってきた。そのようなカルバペネム系化合物
の一つに特公平4-38756号公報に記載の化学式[V]2. Description of the Related Art In recent years, carbapenem compounds have been clinically used as antibiotics having a strong and wide range of antibacterial activities. One of such carbapenem compounds is the chemical formula [V] described in JP-B-4-38756.
【化5】 で示される(1R,5S,6S)−2−[(6,7−ジ
ヒドロ−5H−ピラゾロ[1,2−a][1,2,4]
トリアゾリウム−6−イル)]−チオ−6−[(R)−
1−ヒドロキシエチル]−1−メチル−カルバペネム−
3−カルボキシレートがある。該化合物は、広範囲にわ
たる強力な抗菌活性を有すると共に、化学的、物理的安
定性も良く、生体内における腎デヒドロペプチターゼに
対しても安定なカルバペネム系抗生物質として大いに期
待されている。[Chemical 5] (1R, 5S, 6S) -2-[(6,7-dihydro-5H-pyrazolo [1,2-a] [1,2,4]
Triazolium-6-yl)]-thio-6-[(R)-
1-hydroxyethyl] -1-methyl-carbapenem-
There is 3-carboxylate. The compound has a wide range of strong antibacterial activity, is excellent in chemical and physical stability, and is highly expected as a carbapenem antibiotic that is stable against renal dehydropeptidase in vivo.
【0003】一般式[II]General formula [II]
【化6】 (式中、Rは保護されていてもよいメルカプト基又は酸
残基を表わし、X-は塩形成性陰イオンを表わす。)で
示される化合物(以下、化合物[II]と略記する。)は
上記カルバペネム化合物[V]の2位の修飾基として極
めて有用な化合物であることが特開平4-230286号公報に
記載されている。[Chemical 6] (In the formula, R represents an optionally protected mercapto group or an acid residue, and X − represents a salt-forming anion.) (Hereinafter, abbreviated as compound [II]). It is described in JP-A-4-230286 that the compound is extremely useful as a modifying group at the 2-position of the carbapenem compound [V].
【0004】また、一般式[IV]Further, the general formula [IV]
【化7】 (式中、X-は前記と同じ。)で示される化合物(以
下、化合物[IV]と略記する。)は一般式[II]に於て
Rがメルカプト基である化合物の前駆体物質として極め
て有用であることが特開平4-230267号公報に記載されて
いる。[Chemical 7] The compound represented by the formula (wherein X − is the same as above) (hereinafter abbreviated as compound [IV]) is an extremely precursor substance of the compound in which R is a mercapto group in the general formula [II]. Usefulness is described in JP-A-4-230267.
【0005】化合物[IV]及び一般式[II]に於てRが
メルカプトメチル基である化合物の製造方法として特開
平4-230286号公報及び特開平4-230267号公報に開示され
ている方法は、大略下記反応スキーム[A]で示される
方法である。The method disclosed in JP-A-4-230286 and JP-A-4-230267 is a method for producing compound [IV] and a compound in which R in the general formula [II] is a mercaptomethyl group. In general, the method is represented by the following reaction scheme [A].
【式1】 即ち、化合物[III]にホルムイミド酸エステル類を反
応させて化合物[IV]とし、次いで化合物[IV]のジス
ルフィド結合を還元的に開裂させて化合物[II](但
し、R:メルカプト基)へ誘導する製造方法である。[Formula 1] That is, compound [III] is reacted with formimidate esters to give compound [IV], and then the disulfide bond of compound [IV] is reductively cleaved to give compound [II] (where R is a mercapto group). It is a manufacturing method.
【0006】しかし、この製法で使用するホルムイミド
酸エステル類は湿気などで分解し易いため、長期保存が
できず用時調製して用いる必要があり、さらに市販され
ていないため、入手が困難であるなど、種々の問題点を
抱えており、その改善が望まれていた。However, the formimidic acid esters used in this production method are easily decomposed by moisture and the like, so that they cannot be stored for a long period of time and need to be prepared before use. Further, they are not commercially available, and therefore difficult to obtain. There are various problems such as these, and their improvement has been desired.
【0007】[0007]
【発明の目的】本発明は上記した如き状況に鑑みなされ
たもので、化合物[II]又は化合物[IV]を安定で、且
つ入手が容易な反応試薬を用いて簡便に且つ容易に製造
する方法を提供することを目的とする。DISCLOSURE OF THE INVENTION The present invention has been made in view of the above circumstances, and is a method for easily and easily producing compound [II] or compound [IV] using a stable and easily available reaction reagent. The purpose is to provide.
【0008】[0008]
【発明の構成】上記目的を達成するため、本発明は下記
の構成から成る。 「(1)一般式[I]To achieve the above object, the present invention comprises the following configurations. “(1) General formula [I]
【化8】 (式中、Rは保護されていてもよいメルカプト基又は酸
残基を表わす。)で示される化合物(以下、化合物
[I]と略記する。)又はその酸付加塩にsyn−トリ
アジンを反応させることを特徴とする、一般式[II][Chemical 8] (In the formula, R represents an optionally protected mercapto group or an acid residue.) (Hereinafter abbreviated as compound [I]) or an acid addition salt thereof is reacted with syn-triazine. General formula [II] characterized by
【化9】 (式中、X-は塩形成性陰イオンを表わし、Rは前記と
同じ。)で示される化合物の製造法。[Chemical 9] (In the formula, X − represents a salt-forming anion, and R is the same as the above.).
【0009】(2)化学式[III](2) Chemical formula [III]
【化10】 で示される化合物またはその酸付加塩にsyn−トリア
ジンを反応させることを特徴とする、一般式[IV][Chemical 10] A compound represented by the formula or an acid addition salt thereof is reacted with syn-triazine, represented by the general formula [IV]
【化11】 (式中、X-は前記と同じ。)で示される化合物の製造
法。」[Chemical 11] (In the formula, X − is the same as the above). "
【0010】即ち、本発明者らは、化合物[I]または
化合物[III]或はこれらの酸付加塩に種々の市販の試
薬を反応させ、そのトリアゾール環化反応につき鋭意研
究を行ったところ、syn−トリアジンを反応させると
目的の化合物[II]または化合物[IV]が簡便且つ容易
に得られることを見出し、先に述べた従来法の問題点を
全て解決した本発明を完成するに至った。That is, the present inventors have conducted various studies on the triazole cyclization reaction of the compound [I] or the compound [III] or an acid addition salt thereof with various commercially available reagents. It was found that the desired compound [II] or compound [IV] can be easily and easily obtained by reacting with syn-triazine, and has completed the present invention which solves all the problems of the conventional methods described above. .
【0011】一般式[I]及び[II]に於てRは保護さ
れていてもよいメルカプト基または酸残基を表すが、こ
こで言う酸残基とは広義にプロトン供与性分子から当該
プロトンを除いた残りの原子団を意味する。当該プロト
ン供与性分子としては例えば、酢酸、プロピオン酸、酪
酸、トリフルオロ酢酸等の低級脂肪酸;例えばハロゲン
原子,ニトロ基,低級アルキル基,低級アルコキシ基な
どの置換基を有していても良い安息香酸;メタンスルホ
ン酸、トリフルオロメタンスルホン酸等のハロ低級アル
キルスルホン酸;例えばハロゲン原子,ニトロ基,低級
アルキル基,低級アルコキシ基などの置換基を有してい
ても良いベンゼンスルホン酸;ジメチルリン酸、ジエチ
ルリン酸、ジフェニルリン酸等の有機リン酸、等の有機
酸や、或は硫酸、亜硝酸、硝酸、リン酸、塩酸、臭化水
素酸、ヨウ化水素酸、過塩素酸、ホウフッ化水素酸等の
無機酸等が挙げられる。In the general formulas [I] and [II], R represents an optionally protected mercapto group or an acid residue. The acid residue as used herein means, in a broad sense, a proton donating molecule to the proton. Means the rest of the atomic groups except. Examples of the proton donating molecule include lower fatty acids such as acetic acid, propionic acid, butyric acid, and trifluoroacetic acid; and benzo which may have a substituent such as a halogen atom, a nitro group, a lower alkyl group, and a lower alkoxy group. Acid; halo-lower alkylsulfonic acid such as methanesulfonic acid and trifluoromethanesulfonic acid; benzenesulfonic acid which may have a substituent such as halogen atom, nitro group, lower alkyl group and lower alkoxy group; dimethylphosphoric acid , Organic phosphoric acid such as diethylphosphoric acid, diphenylphosphoric acid, etc., or sulfuric acid, nitrous acid, nitric acid, phosphoric acid, hydrochloric acid, hydrobromic acid, hydroiodic acid, perchloric acid, borofluoride Examples thereof include inorganic acids such as hydrogen acid.
【0012】また、メルカプト基の保護基としては、例
えばペプチド化学の分野においてメチオニン等の含硫ア
ミノ酸のメルカプト基の保護基として用いることのでき
るもので、それ自体既知の任意の保護基等が挙げられ
る。具体例としては、例えばハロゲン原子,ニトロ基,
低級アルキル基,低級アルコキシ基などの置換基を有し
ていても良い、例えばベンゾイル基,フタロイル基もし
くはフェノキシアセチル基などの芳香族カルボン酸アシ
ル基;例えばホルミル基、アセチル基、プロピオニル
基、クロロアセチル基、ブロモアセチル基等の脂肪族カ
ルボン酸アシル基;例えばメタンスルホニル基、トリフ
ルオロメタンスルホニル基、カンファスルホニル基、例
えばハロゲン原子,ニトロ基,低級アルキル基,低級ア
ルコキシ基など置換基を有していても良いベンゼンスル
ホニル基等のスルホン酸アシル基;例えばメトキシカル
ボニル基、エトキシカルボニル基、tert-ブトキシカル
ボニル基、アリルオキシカルボニル基、例えばハロゲン
原子,ニトロ基,低級アルキル基,低級アルコキシ基な
どの置換基を有していても良いベンジルオキシカルボニ
ル基或はフェノキシカルボニル基等のエステル化された
カルボキシル基;例えばハロゲン原子,ニトロ基,低級
アルキル基,低級アルコキシ基などの置換基を有してい
ても良いベンジル基或はフェネチル基等のアラルキル
基;例えばメチルカルバモイル基、エチルカルバモイル
基、フェニルカルバモイル基等のカルバモイル基;チオ
硫酸基及びその塩;例えばチオエチル基、チオtert-ブ
チル基等のチオアルキル基等が挙げられる。The mercapto group-protecting group can be used as a mercapto group-protecting group of a sulfur-containing amino acid such as methionine in the field of peptide chemistry, and includes any known protecting group per se. To be Specific examples include a halogen atom, a nitro group,
Aromatic carboxylic acid acyl groups such as benzoyl group, phthaloyl group or phenoxyacetyl group which may have a substituent such as lower alkyl group and lower alkoxy group; eg formyl group, acetyl group, propionyl group, chloroacetyl group Groups, aliphatic carboxylic acid acyl groups such as bromoacetyl group; eg, having substituents such as methanesulfonyl group, trifluoromethanesulfonyl group, camphorsulfonyl group, such as halogen atom, nitro group, lower alkyl group, lower alkoxy group Sulfonic acid acyl group such as benzenesulfonyl group; substituents such as methoxycarbonyl group, ethoxycarbonyl group, tert-butoxycarbonyl group, allyloxycarbonyl group such as halogen atom, nitro group, lower alkyl group, lower alkoxy group Have Benzyloxycarbonyl group or phenoxycarbonyl group or other esterified carboxyl group; for example, benzyl group or phenethyl group which may have a substituent such as halogen atom, nitro group, lower alkyl group or lower alkoxy group And aralkyl groups such as groups; for example, carbamoyl groups such as methylcarbamoyl group, ethylcarbamoyl group and phenylcarbamoyl group; thiosulfate groups and salts thereof; for example, thioalkyl groups such as thioethyl group and thiotert-butyl group.
【0013】一般式[II]及び[IV]に於て、X-は塩
形成性陰イオンを表わすが、ここで言う塩形成性陰イオ
ンとは、四級アンモニウムの陽イオンに対応する陰イオ
ンを言い、具体的には例えばフッ素アニオン,塩素アニ
オン,臭素アニオン,沃素アニオン等のハロゲンアニオ
ンや、例えばヒドロキシアニオン,メトキシアニオン,
エトキシアニオン等のアルコキシアニオン、或は酸アニ
オンなどが挙げられる。ここで、酸アニオンとは広義に
プロトン供与性分子から当該プロトンを除いた残りの原
子団を意味する。当該プロトン供与性分子としては、例
えば酢酸、プロピオン酸、酪酸、トリフルオロ酢酸、ト
リクロロ酢酸等の低級脂肪酸;安息香酸、p−ニトロ安
息香酸等の置換または未置換の安息香酸;メタンスルホ
ン酸、トリフルオロメタンスルホン酸等の低級アルキル
スルホン酸;トルエンスルホン酸、ベンゼンスルホン酸
等の置換または未置換のアリールスルホン酸;ジメチル
リン酸、ジフェニルリン酸等の有機リン酸、等の有機酸
や、或は亜硝酸、硝酸、硫酸、過塩素酸、ホウフッ化水
素酸等の無機酸等が挙げられる。In the general formulas [II] and [IV], X − represents a salt-forming anion, and the salt-forming anion referred to here is an anion corresponding to a quaternary ammonium cation. Specifically, for example, a halogen anion such as a fluorine anion, a chlorine anion, a bromine anion, an iodine anion, and a hydroxy anion, a methoxy anion,
Examples thereof include alkoxy anion such as ethoxy anion and acid anion. Here, the acid anion broadly means an atomic group remaining after removing the proton from the proton donating molecule. Examples of the proton donating molecule include lower fatty acids such as acetic acid, propionic acid, butyric acid, trifluoroacetic acid and trichloroacetic acid; substituted or unsubstituted benzoic acid such as benzoic acid and p-nitrobenzoic acid; methanesulfonic acid and trifluoroacetic acid. Lower alkyl sulfonic acid such as methane sulfonic acid; substituted or unsubstituted aryl sulfonic acid such as toluene sulfonic acid and benzene sulfonic acid; organic phosphoric acid such as dimethyl phosphoric acid and diphenyl phosphoric acid; Inorganic acids such as nitric acid, nitric acid, sulfuric acid, perchloric acid, and hydrofluoric acid can be used.
【0014】本発明の製造法に於て、化合物[I]又は
化合物[III]或はこれらの酸付加塩に反応させるsy
n−トリアジンは市販品をそのまま使用することがで
き、その使用量は原料化合物である化合物[I]又は化
合物[III]或はこれらの酸付加塩に対して通常約1当
量から約20当量であり、好ましくは約1当量から約10当
量の範囲が良い。化合物[I]又は化合物[III]はそ
のまま用いても、または酸付加塩の形で用いてもどちら
でも良いが、そのまま用いる場合は反応終了後に塩を形
成させるための酸類を添加する必要がある。その酸類は
目的とする前記塩形成性陰イオンを発生させ得る酸であ
れば何れにても良い。In the production method of the present invention, sy is reacted with compound [I] or compound [III] or an acid addition salt thereof.
As n-triazine, a commercially available product can be used as it is, and the amount thereof is usually about 1 to about 20 equivalents relative to the raw material compound [I] or compound [III] or an acid addition salt thereof. And preferably in the range of about 1 equivalent to about 10 equivalents. The compound [I] or the compound [III] may be used as it is, or may be used in the form of an acid addition salt, but when used as it is, it is necessary to add an acid for forming a salt after completion of the reaction. . The acid may be any acid as long as it can generate the desired salt-forming anion.
【0015】反応は通常、溶媒存在下で行われるが、反
応溶媒としては、例えば、水、メタノール,エタノー
ル,プロパノール,ブタノール等のアルコール類、テト
ラヒドロフラン,ジオキサン等のエーテル類、アセトニ
トリル,プロピオニトリル等のニトリル類、アセトン,
メチルエチルケトン等のケトン類、ホルムアミド,ジメ
チルホルムアミド,アセトアミド等のアミド類、酢酸エ
チル,酢酸メチル等のエステル類、クロロホルム,塩化
メチレン等のハロゲン化炭化水素等が挙げられ、夫々単
独で、若しくは適宜二種以上組み合せて混合溶媒として
用いられる。反応温度は特に限定されないが、通常約−
80℃乃至約50℃、好ましくは約−30℃乃至約40℃であ
る。反応時間は反応温度、反応溶媒その他の条件により
若干異るが、通常、数分から数時間で反応が完了するの
で、HPLCなどで追跡し、反応終点を判断すれば良
い。反応後は常法に従って後処理を行えばよく、必要に
応じて、カラムクロマトグラフィーや再結晶等により精
製すれば純度の高い化合物[II]又は化合物[IV]が容
易に得られる。The reaction is usually carried out in the presence of a solvent. Examples of the reaction solvent include water, alcohols such as methanol, ethanol, propanol and butanol, ethers such as tetrahydrofuran and dioxane, acetonitrile, propionitrile and the like. Nitriles, acetone,
Examples thereof include ketones such as methyl ethyl ketone, amides such as formamide, dimethylformamide, acetamide, esters such as ethyl acetate and methyl acetate, halogenated hydrocarbons such as chloroform and methylene chloride, etc., which may be used alone or in appropriate two kinds. The above are combined and used as a mixed solvent. The reaction temperature is not particularly limited, but is usually about −
The temperature is from 80 ° C to about 50 ° C, preferably from about -30 ° C to about 40 ° C. Although the reaction time varies slightly depending on the reaction temperature, the reaction solvent and other conditions, the reaction is usually completed in a few minutes to a few hours, so it may be followed by HPLC or the like to determine the reaction end point. After the reaction, post-treatment may be carried out according to a conventional method, and if necessary, purification can be carried out by column chromatography, recrystallization or the like to obtain a highly pure compound [II] or compound [IV].
【0016】かくして得られた化合物[II]はRがメル
カプト基の場合はそのままカルバペネム化合物の修飾基
として用いることが可能であり、化合物[I]から1工
程で該修飾基が得られることから、製造工程の簡略化、
製造経費の低減化という点において極めて優れた方法で
あると言える。尚、メルカプト基が保護されている場合
は、常法に従って保護基を除去してからこれを用いれば
良い。保護基の除去方法としては、例えばアセチル基や
ベンゾイル基等のエステル保護基は塩酸、硫酸等を用い
た酸加水分解や水酸化ナトリウムや水酸化カリウム等を
用いたアルカリ加水分解などで除去すれば良いし、ベン
ジル基やベンジルオキシカルボニル基等は接触還元反応
で除去することができるのでそのようにして除去する
等、それ自体公知の対応する保護基の脱保護法に従って
行えばこと足りる。また、Rが酸残基の場合は、硫黄や
硫黄化合物、例えば、硫化水素,硫化ナトリウム等の硫
化物、水硫化ナトリウム,水硫化カリウム等の水硫化
物、二硫化ナトリウム,二硫化リチウム等の二硫化物、
チオ酢酸塩類、チオ尿素等を反応させることによりRが
メルカプト基である化合物[II]に容易に変換すること
ができる。更に、化合物[IV]はジスルフィド結合を還
元することにより容易にRがメルカプト基である化合物
[II]に変換することができる。When R is a mercapto group, the compound [II] thus obtained can be used as it is as a modifying group of a carbapenem compound, and the modifying group can be obtained from Compound [I] in one step. Simplification of manufacturing process,
It can be said that this is an extremely excellent method in terms of reduction of manufacturing cost. When the mercapto group is protected, the protecting group may be removed according to a conventional method before use. As a method of removing the protecting group, for example, an ester protecting group such as an acetyl group or a benzoyl group can be removed by acid hydrolysis using hydrochloric acid, sulfuric acid or the like or alkaline hydrolysis using sodium hydroxide, potassium hydroxide or the like. The benzyl group, the benzyloxycarbonyl group and the like can be removed by a catalytic reduction reaction, and thus it is sufficient to follow the known deprotection method of the corresponding protecting group. When R is an acid residue, sulfur or sulfur compounds such as hydrogen sulfide, sulfides such as sodium sulfide, hydrosulfides such as sodium hydrosulfide, potassium hydrosulfide, sodium disulfide, lithium disulfide, etc. Disulfide,
The compound [II] in which R is a mercapto group can be easily converted by reacting thioacetates, thiourea and the like. Furthermore, the compound [IV] can be easily converted to the compound [II] in which R is a mercapto group by reducing the disulfide bond.
【0017】本発明で用いられる出発原料である化合物
[I]は特開平4-230267号公報等に記載された方法に準
じて、下記反応スキーム[B]に従って下記の如き方法
により容易に製造することができるので、そのようにし
て製造したものを用いることで足りる。The compound [I] as a starting material used in the present invention can be easily produced by the following method according to the reaction scheme [B] below according to the method described in JP-A-4-230267. Therefore, it is sufficient to use the product thus produced.
【式2】 [Formula 2]
【0018】即ち、例えば、市販の抱水ヒドラジンを適
当な保護基(R0 1)で保護した後、これをアセトンと反
応させ、ヒドラゾン(a)とする。これにハロゲン化ア
リルを塩基存在下反応させ、脱保護後、適当な保護基
(R0 1,R0 2)で再び保護し、アリルヒドラジン(b)と
する。このアリルヒドラジン(b)に臭素,塩素等のハ
ロゲンを付加してジハロゲン体(c)とした後、これを
炭酸カリウム等の塩基で処理すると、Rがハロゲンであ
る化合物[I0]が得られる。一方、抱水ヒドラジンを適
当な保護基で保護した後、エピクロルヒドリンと反応さ
せてアルコール体(d)とし、この水酸基に例えば塩化
メタンスルホン酸等の酸塩化物を作用させればRが酸残
基である化合物[I0]が得られる。かくして得られた化
合物[I0]のアミノ保護基R0 1,R0 2を常法により脱離さ
せれば化合物[I]が容易に得られる。That is, for example, commercially available hydrazine hydrate is protected with a suitable protecting group (R 0 1 ) and then reacted with acetone to obtain a hydrazone (a). This is reacted with an allyl halide in the presence of a base, deprotected, and then protected again with a suitable protecting group (R 0 1 , R 0 2 ) to give an allyl hydrazine (b). When a halogen such as bromine or chlorine is added to the allyl hydrazine (b) to form a dihalogenated compound (c), which is treated with a base such as potassium carbonate, a compound [I 0 ] in which R is halogen is obtained. . On the other hand, after protecting the hydrazine hydrate with an appropriate protecting group, it is reacted with epichlorohydrin to form the alcohol compound (d), and if an acid chloride such as methane sulfonic acid chloride is allowed to act on this hydroxyl group, R is an acid residue. The compound [I 0 ] is obtained. The compound [I] can be easily obtained by removing the amino protecting groups R 0 1 and R 0 2 of the compound [I 0 ] thus obtained by a conventional method.
【0019】また、化合物[III]は、同じく特開平4-2
30267号公報等に記載された方法に準じて、下記反応ス
キーム[C]に従って、化合物[I0](但し、R=B
r)をチオアセチル化→加水分解→酸化→脱保護するこ
とによっても製造することが出来るし、Further, the compound [III] is the same as in JP-A-4-4-2.
According to the method described in 30267, etc., and according to the following reaction scheme [C], compound [I 0 ] (where R = B
It can also be produced by subjecting r) to thioacetylation → hydrolysis → oxidation → deprotection.
【式3】 或はまた、化合物[I0]又は化合物[I]をアルカリ金
属二硫化物、アルカリ土類金属二硫化物、二硫化アンモ
ニウム、二硫化トリアルキルアンモニウム等の二硫化物
と直接反応させて、一工程でこれを製造することも可能
である。[Formula 3] Alternatively, the compound [I 0 ] or the compound [I] is directly reacted with a disulfide such as an alkali metal disulfide, an alkaline earth metal disulfide, ammonium disulfide, and a trialkylammonium disulfide to give a monosulfide. It is also possible to manufacture it in a process.
【0020】尚、化合物[I0]を原料として後者の方法
により化合物[III]を製造する場合には当然のことな
がら、反応終了後にアミノ保護基(R0 1,R0 2)を常法に
より脱離させる必要がある。尚これらの出発原料は単離
した状態で使用しても良いし、それを製造する最終工程
の反応液のまま使用しても差し支えない。以下に、実施
例を示し本発明をさらに詳しく説明するが、本発明はこ
れら実施例により何ら制約を受けるものではない。When the compound [III] is produced by the latter method using the compound [I 0 ] as a starting material, the amino protecting group (R 0 1 , R 0 2 ) is, as a matter of course, used after the completion of the reaction. Need to be desorbed by. In addition, these starting materials may be used in an isolated state, or may be used as they are in the reaction solution of the final step of producing them. Hereinafter, the present invention will be described in more detail with reference to Examples, but the present invention is not limited to these Examples.
【0021】[0021]
実施例1 4−メルカプト−1,2−ピラゾリジン 0.7g(5mmo
l)の水(40ml)溶液にsyn−トリアジン 2.70g(3
3.3mol)を投入し、10%塩酸でpHを5〜8に調節しな
がら、室温で2時間攪拌、反応させた。反応終了後、10
%塩酸でpHを1以下とし、減圧濃縮して得られた残渣
をメタノール 10mlに溶解した後、不溶物を濾去した。
この操作を2回繰り返した後、母液を減圧濃縮して、得
られた残渣をSP-207カラムクロマト(SP-207 100ml,
水)にて精製した。溶出液を減圧濃縮後、凍結乾燥を行
い目的化合物6,7−ジヒドロ−6−メルカプト−5H
−ピラゾロ[1,2−a][1,2,4]トリアゾリウ
ム塩化物 1.05gを白色結晶として 得た(収率59.1
%)。1 H-NMR(D2O)δppm:4.55ー4.67(3H,m)、5.08-5.15(2H,
m)、9.01(2H,s)Example 1 0.7 g of 4-mercapto-1,2-pyrazolidine (5 mmo
l-) in water (40 ml) 2.70 g (3
3.3 mol) was added, and the mixture was stirred and reacted at room temperature for 2 hours while adjusting the pH to 5 to 8 with 10% hydrochloric acid. After the reaction is complete, 10
The residue obtained by adjusting the pH to 1 or less with% hydrochloric acid and concentrating under reduced pressure was dissolved in 10 ml of methanol, and the insoluble material was filtered off.
After repeating this operation twice, the mother liquor was concentrated under reduced pressure, and the resulting residue was subjected to SP-207 column chromatography (SP-207 100 ml,
Water). The eluate is concentrated under reduced pressure and freeze-dried to obtain the target compound 6,7-dihydro-6-mercapto-5H.
1.05 g of -pyrazolo [1,2-a] [1,2,4] triazolium chloride was obtained as white crystals (yield 59.1
%). 1 H-NMR (D 2 O) δppm: 4.55-4.67 (3H, m), 5.08-5.15 (2H,
m), 9.01 (2H, s)
【0022】実施例2 1,2−ピラゾリジン−4−イル−ジスルフィド・二塩
酸塩 1.40g(5mmol)の水(40ml)溶液に、室温攪拌
下、10%塩酸でpH5〜8に維持しながらsyn−トリ
アジン 1.35g(16.67mmol)のエタノール(32ml)溶液
を滴下し、室温で1.5時間攪拌、反応させた。反応終了
後、10%塩酸でpHを1以下にし、反応液を減圧濃縮し
て得られた残渣をメタノール 10mlに溶解し、不溶物を
濾去した。この操作を2回繰り返し行った後、母液を減
圧濃縮し、得られた残渣にメタノール 6mlとn−プロ
パノール 6mlを加えて溶解し、室温で放置晶析させ
た。析出した結晶を濾取し、真空乾燥して目的化合物
6,7−ジヒドロ−5H−ピラゾロ[1,2−a]
[1,2,4]トリアゾリウム−6−イル−ジスルフィ
ド・二塩化物 1.07gを微黄色プリズム晶として得た
(収率60.6%)。1 H-NMR(D2O)δppm:4.89-4.96(6H,m),5.04-5.17(4H,
m)、9.05(4H,s)Example 2 1,2-pyrazolidin-4-yl-disulfide dihydrochloride 1.40 g (5 mmol) of water (40 ml) in a solution of water (40 ml) was stirred at room temperature with 10% hydrochloric acid to maintain the pH of 5-8. A solution of 1.35 g (16.67 mmol) of triazine in ethanol (32 ml) was added dropwise, and the mixture was stirred and reacted at room temperature for 1.5 hours. After completion of the reaction, the pH was adjusted to 1 or less with 10% hydrochloric acid, the reaction solution was concentrated under reduced pressure, the resulting residue was dissolved in 10 ml of methanol, and the insoluble material was filtered off. After repeating this operation twice, the mother liquor was concentrated under reduced pressure, 6 ml of methanol and 6 ml of n-propanol were added to the obtained residue to dissolve it, and the mixture was allowed to stand at room temperature for crystallization. The precipitated crystals were collected by filtration and dried in vacuum to obtain the target compound 6,7-dihydro-5H-pyrazolo [1,2-a].
1.07 g of [1,2,4] triazolium-6-yl-disulfide dichloride was obtained as slightly yellow prism crystals (yield 60.6%). 1 H-NMR (D 2 O) δppm: 4.89-4.96 (6H, m), 5.04-5.17 (4H,
m), 9.05 (4H, s)
【0023】実施例3 4−ブロモ−1,2−ピラゾリジン 1.87g(10mmol)
の水(25ml)溶液に10%塩酸でpH5〜8に維持しなが
らs−トリアジン 0.54g(6.67mmol)のエタノール(2
5ml)溶液を滴下し、室温で1時間攪拌、反応させた。
反応終了後、10%塩酸でpHを1以下にし、反応液を減
圧濃縮して得られた残渣をメタノール 20mlに溶解し、
不溶物を濾去した。この操作を2回繰り返し行った後、
メタノールを減圧濃縮し、得られた残渣をn−プロパノ
ール 10mlに溶解した。この溶液にアセトン 10mlを注入
し、晶出した結晶を窒素気流下濾取、乾燥して目的化合
物6,7−ジヒドロ−6−ブロモ−5H−ピラゾロ
[1,2−a][1,2,4]トリアゾリウム塩化物
1.31gを白色結晶として得た(収率58.5%)。1 H-NMR(D2O)δppm:5.13ー5.17(4H,t like),5.50-5.60(1
H,m),9.10(2H,s)Example 3 1.87 g (10 mmol) of 4-bromo-1,2-pyrazolidine
S-triazine (0.54 g, 6.67 mmol) in ethanol (2 ml) while maintaining pH 5-8 with 10% hydrochloric acid in water (25 ml).
(5 ml) solution was added dropwise, and the mixture was stirred and reacted at room temperature for 1 hour.
After the reaction was completed, the pH was adjusted to 1 or less with 10% hydrochloric acid, the reaction solution was concentrated under reduced pressure, and the resulting residue was dissolved in 20 ml of methanol.
The insoluble material was filtered off. After repeating this operation twice,
Methanol was concentrated under reduced pressure, and the obtained residue was dissolved in 10 ml of n-propanol. 10 ml of acetone was poured into this solution, and the crystallized crystals were collected by filtration under a nitrogen stream and dried to give the desired compound 6,7-dihydro-6-bromo-5H-pyrazolo [1,2-a] [1,2, 4] Triazolium chloride
1.31 g was obtained as white crystals (yield 58.5%). 1 H-NMR (D 2 O) δppm: 5.13-5.17 (4H, t like), 5.50-5.60 (1
H, m), 9.10 (2H, s)
【0024】[0024]
【発明の効果】本発明によれば、カルバペネム系抗生物
質の修飾基として有用な6,7−ジヒドロ−5H−ピラ
ゾロ[1,2−a][1,2,4]トリアゾリウム類
を、安定で、且つ入手が容易な反応試薬を用いて、従来
の方法よりも簡便、且つ容易に製造することができる点
に顕著な効果を奏する。INDUSTRIAL APPLICABILITY According to the present invention, 6,7-dihydro-5H-pyrazolo [1,2-a] [1,2,4] triazolium compounds useful as a modifying group for carbapenem antibiotics can be stably In addition, it has a remarkable effect in that it can be produced more easily and easily than the conventional method by using a reaction reagent which is easily available.
フロントページの続き (72)発明者 谷 力 埼玉県川越市大字的場1633 和光純薬工業 株式会社東京研究所内Front page continuation (72) Inventor Tani Riki 1633 Matoba, Kawagoe City, Saitama Prefecture Wako Pure Chemical Industries, Ltd. Tokyo Research Laboratory
Claims (2)
残基を表わす。)で示される化合物又はその酸付加塩に
syn−トリアジンを反応させることを特徴とする、一
般式[II] 【化2】 (式中、X-は塩形成性陰イオンを表わし、Rは前記と
同じ。)で示される化合物の製造法。1. A compound represented by the general formula [I]: (Wherein R represents a mercapto group or an acid residue which may be protected) or an acid addition salt thereof is reacted with syn-triazine. Chemical 2] (In the formula, X − represents a salt-forming anion, and R is the same as the above.).
ジンを反応させることを特徴とする、一般式[IV] 【化4】 (式中、X-は塩形成性陰イオンを表す。)で示される
化合物の製造法。2. A chemical formula [III]: The compound represented by the formula or an acid addition salt thereof is reacted with syn-triazine, represented by the general formula [IV]: (In the formula, X − represents a salt-forming anion).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5245911A JPH0776585A (en) | 1993-09-06 | 1993-09-06 | Production of 6,7-dihydro-5h-pyrazolo(1,2-a)(1,2,4)triazoliums |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5245911A JPH0776585A (en) | 1993-09-06 | 1993-09-06 | Production of 6,7-dihydro-5h-pyrazolo(1,2-a)(1,2,4)triazoliums |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0776585A true JPH0776585A (en) | 1995-03-20 |
Family
ID=17140671
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5245911A Withdrawn JPH0776585A (en) | 1993-09-06 | 1993-09-06 | Production of 6,7-dihydro-5h-pyrazolo(1,2-a)(1,2,4)triazoliums |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0776585A (en) |
-
1993
- 1993-09-06 JP JP5245911A patent/JPH0776585A/en not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU182082B (en) | Process for the elimination of allyl and allyloxy-carbonyl groups resp. from allyl esters, carbonates and allyl esters of n-substituted carboxylic acids | |
US20020095034A1 (en) | Imipenem production process | |
EP0018546B1 (en) | Process for the production of phenylglycyl chloride hydrochlorides | |
ES2328117T3 (en) | PROCESS FOR THE PREPARATION OF IMIPENEM. | |
JPH0776585A (en) | Production of 6,7-dihydro-5h-pyrazolo(1,2-a)(1,2,4)triazoliums | |
JPS5936914B2 (en) | Cephalosporin analogs | |
IE49368B1 (en) | Cephalosporin derivatives | |
KR100472048B1 (en) | Novel method for producing Aztreonam | |
EP0445822A1 (en) | Thiazolinoazetidinone derivative and process for preparing 2-exo-methylene-penam derivative thereform | |
US20060009639A1 (en) | Process for the preparation of cefpodoxime proxetil | |
US4237280A (en) | Intermediate for cephalosporin type compound | |
US5463075A (en) | Process for preparing 1,2-pyrazolidine-4-yl-disulfide compound | |
CN113185538B (en) | Preparation method of cefpodoxime acid | |
JPH04230290A (en) | Production of carbapenem compound | |
KR930007810B1 (en) | Process for preparing 7-acylamino-3-vinyl cephalosporanic acid | |
KR960011779B1 (en) | Novel process for preparing crystalline hydrate of cephalosporin | |
KR870000724B1 (en) | Process for preparing cephalosphorin derivatives | |
JPS59101485A (en) | Azetidinone derivative and its preparation | |
KR960011780B1 (en) | Novel process for preparing crystalline hydrate of cephalosporine | |
HUT59687A (en) | Process for producing 7-amino-3-methoxy-methyl-ceph-3-eme-4-carboxylic acid | |
KR930007816B1 (en) | Process for preparing cephem compound | |
KR100388108B1 (en) | New process for producing intermediates of cephalosporin antibiotics | |
KR100400497B1 (en) | Novel method for preparation of cephem derivatives or salts thereof | |
KR100400498B1 (en) | Novel method for preparation of cephem derivatives or salts thereof | |
KR100432425B1 (en) | Novel method for preparation of cephem derivatives or salts thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A300 | Withdrawal of application because of no request for examination |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 20001107 |